Press Releases

SAN DIEGO and CALGARY, Alberta, Jan. 13, 2020 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) (TSX: ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today provided a recap of a Key Opinion Leader call sponsored by ROTH Capital Partners which was held on

NEW YORK, Jan. 13, 2020 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the sale of substantially all of the assets of its portfolio company, Trust Healthcare Consulting Services, LLC ("TrustHCS" or the "Company"), to a healthcare joint ve

PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA), submitted under the 505(b)(2) regulatory pathway, for Cocaine Hydrochloride (HCl) Nasal Solution 4% (40 mg/mL), the company's branded local anesthetic product. 

ARAZLO Lotion Demonstrated Statistically Significant Superiority Over Placebo with Favorable Efficacy, Safety and Tolerability ProfilePost Hoc Analysis of the Two Phase 3 Studies Also Published in JDD BRIDGEWATER, N.J., Jan. 13, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatol

VAUGHN, Ontario, Jan. 13, 2020 /PRNewswire/ -- Ignite International Brands, Ltd. (CSE: BILZ; OTCQX: BILZF) ("IGNITE" or the "Company") announces today that it is continuing with its plans to focus on expanding distribution, both domestically (within North America) and internationally, in addition to introducing new prod

SEATTLE and VANCOUVER, British Columbia, Jan. 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), University of Bristol, and Oracle Corporation (NYSE: ORCL) today announced the outcome of a study using Oracle's high-performance cloud infrastructure to potentially improve the speed of

INDIANAPOLIS, Jan. 13, 2020 /PRNewswire/ -- Today, Eli Lilly and Company (NYSE: LLY) jointly announced with Innovent Biologics, Inc. the results of a Phase 3 study in China; the ORIENT-11 trial of Tyvyt® (sintilimab injection) in combination with ALIMTA® (pemetrexed) and platinum in first-line advanced o

WALTHAM, Mass., Jan. 13, 2020 /PRNewswire/ -- Boston IVF, a national leader in reproductive care and fertility research, announced today that its Board of Directors has appointed David Stern, MBA as Chief Executive Officer, effective January 6, 2020. With more than 25 years of experience in the women's hea

VANCOUVER, Wash., Jan. 13, 2020 /PRNewswire/ -- AbSci, the Protein Printing™ company with a best-in-class E. coli cell line for rapid and low-cost biomanufacturing of complex biotherapeutics, today announced the completion of a $10.4M Series D financing led by KBI Biopharma and JSR Life Sciences. Existing investors Phoenix

OTTAWA, Jan. 13, 2020 /PRNewswire/ - Autonomous_ID Corporation said today that Denis R. Hebert has joined the Chairman's Advisory Board as a principal advisor on biometric identity and access-control systems.  Hebert's appointment comes as the company pivots from research to real-world deployments of its gait-based biometric identification system and Internet-of-